Background

Content Library

Filter
Type
Topic
Product
  • Publication
  • Aug 28, 2017
Investigating Protein-Peptide Interactions Using the Schr’dinger Computational Suite
Bhachoo, et al. Methods Mol Biol., 2017, 1561, 235-254
  • Publication
  • Sep 8, 2015
PrimeX and the Schrödinger computational chemistry suite of programs
Bell, et al. International Tables for Crystallography, Volume F: Crystallography of biological macromolecules, 2012, 18, 534-538
  • Publication
  • Sep 8, 2015
Allosteric Inhibition of the NS2B-NS3 Protease from Dengue Virus
Yildiz, et al. ACS Chem. Biol., 2013, 8(12), 2744-2752
  • Publication
  • Sep 8, 2015
Significant reduction in errors associated with non-bonded contacts in protein crystal structures: Automated all-atom refinement with PrimeX
Bell, et al. Acta. Crystallogr. D Biol. Crystallogr., 2012, 68(Pt 8), 935-952
  • Publication
  • Sep 8, 2015
The crystal structure of DehI reveals a new ‘-haloacid dehalogenase fold and active-site mechanism
Schmidberger, et al. J. Mol. Biol., 2008, 378, 284-294
  • Publication
  • Sep 8, 2015
Structure of the Arabidopsis thaliana TOP2 oligopeptidase
Wang, et al. Acta. Crystallogr. F Struct. Biol. Commun., 2014, 70(Pt 5), 555-559
  • Publication
  • Sep 8, 2015
A Structure-Based Model for Predicting Serum Albumin Binding
Lexa, et al. PLoS ONE, 2014, 9(4), e93323
dark theme background

Latest insights from Extrapolations blog

With FEP+, “The Experiment is the Limit.”
With FEP+, “The Experiment is the Limit.”

Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.

Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods (FEP)
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods

The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.

Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In

We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.

Training & Resources

Online certification courses

Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.

Free learning resources

Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.